GTBP - Nilai Total Perusahaan GT Biopharma, Inc.

Tandha merek GT Biopharma, Inc. (GTBP)

The GT Biopharma, Inc. (GTBP) ecosystem relies on TriKE technology for the targeted activation of NK cells in the therapy of hematological and solid neoplasms. This price chart, which serves as confirmation of the market valuation, shows an Enterprise Value of 6.31. GT Biopharma, Inc. (GTBP) delegates clinical trials and protein production to external contractors (CRO/CMO). Currently, the business's success depends on drug tests against myeloleukemia and the regular raising of capital to cover R&D expenses.

GTBP: Nilai Perusahaan GT Biopharma Corp 23.11.2025 - 29.10.2026

Ringkesan rincian data analitis GT Biopharma, Inc. (GTBP)

- rega saiki lan proyeksi nilai saham:
Rega GT Biopharma Inc|GTBP - Prakiraan konsensus analis
- statistik kapitalisasi pasar:
Nilai pasar GT Biopharma|GTBP - Nilai Total Perusahaan
- rincian valuasi buku bisnis:
Nilai Buku Saham GT Biopharma|GTBP - Kapitalisasi Buku|Rasio Kapitalisasi marang Aset Bersih gtbiopharma.com|GTBP - Total Aset Perusahaan
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal GT Biopharma, Inc.|GTBP - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang modal gtbiopharma.com|GTBP - Gunggung utang perusahaan|Utang marang nilai buku GT Biopharma|GTBP - Utang jangka dawa perusahaan|Utang jangka cendhak GT Biopharma|Rasio jangkoan perantara gtbiopharma.com
- informasi bathi lan kelipatan valuasi:
GTBP - Penghasilan resik
Ringkesan analitik perusahaan:GTBP - GT Biopharma Inc
Produk asli GT Biopharma Inc

Enterprise Value modeling for GT Biopharma, Inc. (GTBP) allows for an assessment of the actual business acquisition cost by summing market capitalization and net debt. This indicator reveals the true price of assets, accounting for cold chain costs for transporting oncology drugs, which helps investors distinguish a temporary price correction from a systemic devaluation of the company's high-tech logistical infrastructure.

Karo sapa GT Biopharma, Inc. saingan

Total Nilai Bisnis TGTX (TG Therapeutics Inc)|Arcellx Corp - Nilai Perusahaan|IRON: Nilai Total Perusahaan|Syndax Pharmaceuticals (SNDX) - Nilai Total Perusahaan|Nilai Wutuh Bisnis KURA (kuraoncology.com)|ADCT (ADC Therapeutics SA) - Nilai Perusahaan|Rega Nyata Tumbas Perusahaan Kanthi Wutuh Foghorn (FHTX)|Nilai Perusahaan VOR|Nilai Perusahaan nkartatx.com (NKTX)|Nilai Total Perusahaan Coeptis Therapeutics, Inc. COEP|ATNM: Nilai Bisnis|Estrella Immunopharma, Inc. - Nilai Perusahaan|CASI Pharmaceuticals (CASI) - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|MRKR: Nilai Perusahaan|Total Nilai Perusahaan IN8bio Inc (INAB)|Nilai Total Perusahaan Eterna Therapeutics, Inc.|APTO: Nilai Dipunlarasaken Utang lan Kas|Rega Nyata Tumbas Perusahaan Kanthi Wutuh BPTH (Bio-Path Holdings, Inc.)|MEIP (MEI Pharma Inc) - Nilai Dipunlarasaken Utang lan Kas|Nilai Perusahaan VINC (Vincerx Pharma)